0001183740-24-000039.txt : 20240503 0001183740-24-000039.hdr.sgml : 20240503 20240502193842 ACCESSION NUMBER: 0001183740-24-000039 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240502 EFFECTIVENESS DATE: 20240503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRIGHT MINDS BIOSCIENCES INC. CENTRAL INDEX KEY: 0001827401 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-512284 FILM NUMBER: 24910351 BUSINESS ADDRESS: STREET 1: 19 VESTRY STREET CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 6474072515 MAIL ADDRESS: STREET 1: 19 VESTRY STREET CITY: NEW YORK STATE: NY ZIP: 10013 D 1 primary_doc.xml X0708 D LIVE 0001827401 BRIGHT MINDS BIOSCIENCES INC. 19 VESTRY STREET NEW YORK NY NEW YORK 10013 (647) 865-8622 BRITISH COLUMBIA, CANADA 1210954 BC Ltd. None Corporation true 2019 IAN McDONALD 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Director Chief Executive Officer and President RYAN CHEUNG 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Chief Financial Officer MARK SMITH 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Chief Medical Officer NILS CHRISTIAN BOTTLER 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director JEREMY FRYZUK 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director JAN PEDERSEN 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Executive Officer Director Chief Science Officer DAVID WEINER 19 VESTRY STREET NEW YORK NY NEW YORK 10013 Director Biotechnology Decline to Disclose 06b false 2024-03-22 true true true true true Share purchase options ("Options") granted pursuant to the Common Stock Option Plan of the Company. Each Option is exercisable to purchase one common share of the Company at C$1.84 for a period of 5 years from the date of grant. false 0 54160 0 54160 Total Offering Amount represents the exercise price of Options (40,000 x $1.354* | C$1.84). There is no assurance that the Options will be exercised prior to expiry on March 22, 2029. *C$1=$0.7357 false 2 0 0 0 false BRIGHT MINDS BIOSCIENCES INC. /s/ Ian McDonald Ian McDonald President and CEO 2024-05-02